China would make a necessary response in the event of a trade war with the United States but added that such a war would only harm all sides. Speaking on the sidelines of an annual meeting of China’s parliament, Wang said China had no intention of displacing the United States and that the two countries did not have to be rivals but should strive to be partners. U.S. President Donald Trump is expected to establish tariffs of 25 percent on imported steel and 10 percent on imported aluminium this week, but the White House has said there could be a 30-day exemption for Mexico and Canada and some other countries based on national security. Such a move aims to counter cheap imports, especially from China, that Trump says undermine U.S. industry and jobs. Wang sid that history has shown trade wars were not the correct way to resolve problems. “Especially given today’s globalisation, choosing a trade war is a mistaken prescription. The outcome will only be harmful,” Wang said. “China would have to make a justified and necessary response,” he said. Wang said China had a long way to go on its path of modernisation, and that it “will not and need not displace the United States.” Trump addressed trade with China in tweets on Wednesday, demanding that it lay out plans for reducing its trade surplus with the United States by $1 billion, which appeared to have been raised during a meeting with a top Chinese official last week. “China has been asked to develop a plan for the year of a One Billion Dollar reduction in their massive Trade Deficit with the United States,” Trump tweeted, without saying where the message had been conveyed. China ran a record goods trade surplus with the United States last year of $375.2 billion. Frozen Mechanism Trade tensions between the world’s two largest economies have risen since Trump took office in 2017, and although China only accounts for a small fraction of U.S. steel imports, its massive industry expansion has helped produce a global glut of steel that has driven down prices. Trump is also considering potential trade sanctions against China under a “Section 301” investigation into its intellectual property practices and pressure on foreign companies for technology transfers. Diplomatic and U.S. business sources say the United States has all but frozen a formal mechanism for talks on commercial disputes with China because it is not satisfied it has met its promises to ease market restrictions. China’s latest trade date released on Thursday showed its February exports rose 44.5 percent from a year earlier, beating market expectations, while imports grew 6.3 percent. That left it with a trade surplus of $33.74 billion for the month. China’s trade performance rebounded in 2017 and logged a strong start this year thanks to robust demand at home and abroad. But the rapidly escalating trade tensions with the United States are clouding the outlook for exports, while a cooling property market may curb domestic demand for imported raw materials such as iron ore.China’s foreign minister Wang Yi said on Thursday that
Nunes said. “We continue to get facts. We will bring those facts forward as we see them.” Nunes said there is evidence of collusion, but added it occurred between the Democratic Party, Hillary Clinton, and the Russians. “I welcome anybody to come help investigate, because so far it’s only the House Intelligence Committee Republicans who are actually doing anything to get to the bottom of who was colluding with Russia,” he concluded. “The more we peel this back, we have clear evidence of collusion but it’s not between the Trump campaign, it’s between the Democratic party and the Hillary campaign and the Russians.”Republican Rep. Devin Nunes of California shared some startling news about the Russia investigation Saturday, claiming there was clear evidence of collusion on Fox News’ “Cavuto Live.” Nunes said he welcomes more investigators to look into Foreign Intelligence Surveillance Act (FISA) court abuses and said he is glad the Inspector General is getting involved. “We have a media that pretty much refuses to cover this issue at all. We have serious abuses that occurred in the FISA court against the Trump campaign,”
By Tuesday, February 06, 2018
CDC officials disregarded the incompatibility of Danish vs. U.S. infants’ exposure to 75% higher doses of thimerosal; despite the incongruity, they chose Denmark as a population study comparator.CDC officials selected a Danish network of scientists who were either employed by the Danish vaccine manufacturer, Statens Serum Institut (SSI), or worked at institutions closely connected to SSI, such as the Danish Epidemiology Science Center, and Aarhus University. The details of how the studies’ results were premeditated are revealed in internal CDC email correspondence . The Danish studies were crafted to deliver “proof of innocence” to offset Dr. Verstraeten’s evidence documenting a disturbing Thimerosal-autism risk; and they were crafted to refute Dr. Wakefield’s suggestion of an autism-MMR connection.
CDC disregarded the scientific reservations about comparing “apples to pears”Dr. Verstraeten expressed concern about scientific dishonesty in an email (dated July 14, 2000) addressed to Harvard professor, Dr. Philippe Grandjean, an expert in heavy metals toxicity, (copies addressed to Chen, DeStefano, and four other CDC scientists) he stated: “many experts looking at this thimerosal issue, do not seem bothered to compare apples to pears… I do not wish to be the advocate of the anti-vaccine lobby and sound like being convinced that thimerosal is or was harmful, but at least I feel we should use sound scientific argumentation and not let our standards be dictated by our desire to disprove an unpleasant theory.” CDC officials sought to obtain reports that would provide the appearance of scientific evidence that thimerosal, the mercury-based vaccine additive is safe, the MMR is safe, and that vaccines do not cause autism. Dr. Diane Simpson, the CDC official tasked with obtaining proof to offset Dr. Verstraeten’s demonstrated thimerosal-autism risk, traveled to Denmark in 2001 where she met with a network of Danish scientists. CDC provided tens of millions of dollars in grants to a Danish team at the University of Aarhus in Denmark; the management of the grants was entrusted to psychiatrist Poul Thorsen, who had been a CDC “visiting scientist” in 1990. At Thorsen’s recommendation, Simpson recruited Kreesten Madsen, a doctoral candidate, who was listed as the lead author on several pivotal Danish studies. However, the principal scientist who co-authored those studies was, in fact Thorsen. Beyond the continued influence of fraudulent CDC and CDC-sponsored Danish epidemiological studies, Thorsen was a participant in a pivotal Working Group of the American Psychiatric Association (APA), which led to the controversial re-defining of the criteria for an autism diagnosis in the DSM-5, psychiatry’s diagnostic “bible”; the new DSM-5 criteria reduced the autism prevalence rate substantially. In another email addressed to Dr. Chen (2001), Dr. Verstraeten expressed serious doubts about the reliability of the UK General Practice Research Database (GPRD) which numerous authors have continued to rely on, to support the claim that there is “no evidence of a causal association between thimerosal and autism”. “I think two issues are important in assessing the potential strength of the GPRD study:.1. Maximum exposure and 2. Unbiased controls. I’m not sure if the GPRD is that reliable that you can be sure that low exposure is really low exposure and not underascertainment in the database. I hate to say this, but given these concerns, it may not be worth doing this after all. On the other hand, maybe the [WHO] grant can be given to Herald in Sweden to do a follow-up of the DTaP trial.” (June 26, 2001) Dr. Verstraeten’s criticism of the GPRD alarmed Dr. Miller who expressed her concern (in an email to Chen): “Do I have to give my GPRD grant money from WHO back”?
The CDC VSD study (1999) led by Dr. Verstraeten, underwent a series protocol manipulations and statistical tricks aimed at eliminating the 7.6 relative increased risk of autism from exposure to thimerosal.During a four year “evolution”, the study’s original conclusion – an increased risk factor of 7.6 – a risk that Dr. Verstraetn had indicated in 1999 – “it just won’t go away” – was systematically reduced at each phase in a series of 5 protocol modifications – even after his departure from CDC for GSK in June 2001. In phase 2, infants’ exposure to Thimerosal was compared at 3 months rather than 1 month – when infants are their most vulnerable; the original 400,000 records from the 4 HMOs, were reduced to 124,170 records from 2 HMOs, with the addition of records from the Harvard Pilgrim HMO – which used different diagnostic codes than the other two – (and whose records’ accuracy was in doubt.) These changes reduced the relative risk to 2.48. In phase 3, the age criteria of the children included, was changed from (0 to 6 years) to (0 to 3). A cut off at age 3 eliminated a significant number of children who were subsequently diagnosed, but not counted in the study. This was acknowledged by Dr. Coleen Boyle in an internal email to Dr. Frank DeStefano (April, 2000): “For me the big issue is the missed cases — and how this relates to exposure. Clearly there is gross underreporting… Considering that the average age of diagnosis of autism in the VSD database was 44 to 49 months it is easy to see that almost half of the children in the database were too young to be diagnosed.” This dubious cut-off resulted in reducing the relative risk 1.69. A manuscript was submitted for publication but was rejected by the journal Epidemiology. Two more “modifications” wiped the risk out of existence. The study was then submitted for publication to Pediatrics (2003). The study’s illegitimate, manipulated findings exonerating Thimerosal were widely publicized. In October 2003, Congressman Dave Weldon, MD raised serious concerns in a letter to CDC Director, Julie Gerberding, citing specific issues undermining the scientific integrity of the CDC Pediatric study, and CDC’s undue influence on the IOM report: “I found a disturbing pattern which merits a thorough, open, timely, and independent review by researchers outside of the CDC, HHS, the vaccine industry, and others with a conflict of interest in vaccine related issues (including many in University settings who may have conflicts)… A review of these documents leaves me very concerned that rather than seeking to understand whether or not some children were exposed to harmful levels of mercury in childhood vaccines in the 1990s there may have been a selective use of the data to make the associations in the earliest study disappear. Furthermore, the lead author of the article, Dr. Thomas Verstraeten worked for the CDC until he left over two years ago to work in Belgium for GlaxoSmithKline (GSK) a vaccine manufacturer facing liability over TCVs [thimerosal containing vaccines]. In violation of their own standards of conduct, Pediatrics failed to disclose that [serious conflict of interest]. “In reviewing the study there are data points where children with higher exposures to the neuortoxin mercury had fewer developmental disorders. This demonstrates to me how excessive manipulation of data can lead to absurd results.” [Highlight added] Internal email correspondence reveal a culture at CDC that is intent on shielding vaccines and the childhood vaccination schedule at any cost. That culture was the subject of a follow up letter by Congressman Weldon to CDC Director, Dr. Julie Gerberding (January 2004): “For too long, those who run our national vaccination program have viewed those who have adverse reactions, including those with severe adverse reactions, as the cost of doing business… It appears to me not only as a Member of Congress but also as a physician that some officials within the CDC’s NIP may be more interested in a public relations campaign than getting to the truth about thimerosal.” Public distrust in government vaccine safety pronouncements is validated in documented evidence showing that CDC-sponsored published reports are the product of scientific fraud, in violation of legally mandated, ethical requirements, and malfeasance by high level CDC officials. In 2011, Poul Thorsen was indicted by a federal grand jury on 22 criminal counts of forgery, money laundering, embezzlement, among others, whereupon he fled the country to Denmark and remains a fugitive from justice. In 2012, Thorsen was added to the Office of Inspector General’s “Most Wanted” list of criminals. At the very least, Thorsen’s documented criminal actions clearly call into question the validity of those CDC-sponsored Danish epidemiological reports whose inordinate influence continues to permeate the vaccine literature and vaccination policies. Yet, the academic community, and the medical journals – with the exception of Nature Online – have maintained a deafening silence – even as the evidence of fraud and criminality by the principal scientist of the Danish studies was laid bare. What was also laid bare in internal correspondence is that CDC officials colluded with Thorsen’s Danish team in deception and fraud in the preparation of autism research studies for publication. In January 2011, BMJ Editor-in-chief, Dr. Fiona Godlee, reignited and intensified the campaign against Andrew Wakefield, by launching an unprecedented assault that declared his research to be “fraudulent”, and Dr. Wakefield guilty of “elaborate fraud.”
Was the timing of BMJ assault a coincidence?The BMJ assault was launched at the very moment that conclusive evidence of far-reaching, elaborate scientific fraud was uncovered in CDC internal documents. These documents also provided the US Inspector General with evidence of elaborate criminal actions committed by Poul Thorsen, MD, PhD (dubbed “Master Manipulator” in a book by James Grundvig, 2016). Thorsen was the principal investigator of the pivotal CDC-commissioned Danish studies that declared that neither thimerosal nor the MMR posed a risk of autism. CDC relies on those studies to dismiss evidence of serious risks posed by the MMR and thimerosal for young children. Whereas Poul Thorsen’s extensive fraud and malfeasance was substantiated by evidence; Dr. Godlee’s charge of fraud against Andrew Wakefield was made without a shred of evidence. Internal correspondence document that the CDC commissioned Danish studies were designed and manipulated to provide the pre-determined exoneration of Thimerosal as a causative trigger for autism. The authors delivered the “evidence” that CDC sought (and paid millions to obtain) in its effort to quell public suspicions that an autism epidemic has been triggered by (a) vaccines laced with mercury (thimerosal) and/or (b) the combined measles/mump/ rubella (MMR) vaccine. The six Danish studies are:
- Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M, New England Journal of Medicine, 2002;
- Hviid A, Stellfeld M, Wohlfahrt J, JAMA 2003;
- Madsen KM, Lauritsen, MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH and Mortensen PB, Pediatrics, 2003;
- Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. American Journal of Preventive Medicine, 2003;
- Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, Schendel D, Thorsen P, Mortensen PB. American Journal of Epidemiology, 2005;
- Lauritsen MB, Jørgensen M, Madsen KM, Lemcke S, Toft S, Grove J, Schendel DE, Thorsen P. Journal of Autism and Developmental Disorders 2010
- Inconsistent inclusion criteria: Prior to 1993, only inpatient autism cases were reported in the Danish registry; representing only 10% of autism cases. Following the removal of Thimerosal from childhood vaccines in 1992, patients from a large Copenhagen outpatient clinic were added. But the authors excluded these cases from the report. In 1995, a new Danish registry was introduced to include all outpatients. These existing, previously unregistered patients were counted by the investigators as new—thereby artificially increasing the number of reported autism cases significantly.
- Inconsistent diagnostic criteria: In 1994, Denmark changed the diagnostic criteria for autism from “psychosis proto-infantilis” to the more commonly used “childhood autism” to determine a diagnosis. The diagnostic criteria require autism to be identified before a child is three years old. But the authors misrepresented newly registered outpatient cases – many of who were children between the ages of 7 and 9 as “newly diagnosed.”
- Deletion of data: The authors also deleted the entire year 2001 data for seven year old children from the final published report. This constitutes flagrant research fraud. Blaxill also invalidated the Danish mercury vaccine exposure experience as not a proper comparator: